Search
00
GBAF Logo
trophy
Top StoriesInterviewsBusinessFinanceBankingTechnologyInvestingTradingVideosAwardsMagazinesHeadlinesTrends

Subscribe to our newsletter

Get the latest news and updates from our team.

Global Banking and Finance Review

Global Banking & Finance Review

Company

    GBAF Logo
    • About Us
    • Profile
    • Privacy & Cookie Policy
    • Terms of Use
    • Contact Us
    • Advertising
    • Submit Post
    • Latest News
    • Research Reports
    • Press Release
    • Awards▾
      • About the Awards
      • Awards TimeTable
      • Submit Nominations
      • Testimonials
      • Media Room
      • Award Winners
      • FAQ
    • Magazines▾
      • Global Banking & Finance Review Magazine Issue 79
      • Global Banking & Finance Review Magazine Issue 78
      • Global Banking & Finance Review Magazine Issue 77
      • Global Banking & Finance Review Magazine Issue 76
      • Global Banking & Finance Review Magazine Issue 75
      • Global Banking & Finance Review Magazine Issue 73
      • Global Banking & Finance Review Magazine Issue 71
      • Global Banking & Finance Review Magazine Issue 70
      • Global Banking & Finance Review Magazine Issue 69
      • Global Banking & Finance Review Magazine Issue 66
    Top StoriesInterviewsBusinessFinanceBankingTechnologyInvestingTradingVideosAwardsMagazinesHeadlinesTrends

    Global Banking & Finance Review® is a leading financial portal and online magazine offering News, Analysis, Opinion, Reviews, Interviews & Videos from the world of Banking, Finance, Business, Trading, Technology, Investing, Brokerage, Foreign Exchange, Tax & Legal, Islamic Finance, Asset & Wealth Management.
    Copyright © 2010-2025 GBAF Publications Ltd - All Rights Reserved.

    ;
    Editorial & Advertiser disclosure

    Global Banking and Finance Review is an online platform offering news, analysis, and opinion on the latest trends, developments, and innovations in the banking and finance industry worldwide. The platform covers a diverse range of topics, including banking, insurance, investment, wealth management, fintech, and regulatory issues. The website publishes news, press releases, opinion and advertorials on various financial organizations, products and services which are commissioned from various Companies, Organizations, PR agencies, Bloggers etc. These commissioned articles are commercial in nature. This is not to be considered as financial advice and should be considered only for information purposes. It does not reflect the views or opinion of our website and is not to be considered an endorsement or a recommendation. We cannot guarantee the accuracy or applicability of any information provided with respect to your individual or personal circumstances. Please seek Professional advice from a qualified professional before making any financial decisions. We link to various third-party websites, affiliate sales networks, and to our advertising partners websites. When you view or click on certain links available on our articles, our partners may compensate us for displaying the content to you or make a purchase or fill a form. This will not incur any additional charges to you. To make things simpler for you to identity or distinguish advertised or sponsored articles or links, you may consider all articles or links hosted on our site as a commercial article placement. We will not be responsible for any loss you may suffer as a result of any omission or inaccuracy on the website.

    Home > Finance > Healthcare, real estate losses drag UK shares; Fed in focus
    Finance

    Healthcare, real estate losses drag UK shares; Fed in focus

    Healthcare, real estate losses drag UK shares; Fed in focus

    Published by Global Banking and Finance Review

    Posted on May 7, 2025

    Featured image for article about Finance

    (Reuters) -British stocks closed lower on Wednesday as losses in healthcare and real estate shares offset positive trade talk developments, while investors awaited the U.S. Federal Reserve's interest rate decision due later in the day.

    The blue-chip FTSE 100 fell 0.4%.

    The domestically focused FTSE 250 slipped 0.1%.

    However, brokerage Barclays upgraded the FTSE 250 to 'overweight' from 'market weight', expecting stocks to benefit from the Bank of England's interest rate cuts, with one expected on Thursday.

    Healthcare stocks led the decline among sectors, down 2.2%, after the U.S. Food and Drug Administration named Vinay Prasad, an oncologist who has previously criticized FDA leadership and COVID-19 mandates, as the director of its Center for Biologics Evaluation and Research.

    Shares of AstraZeneca and GSK fell 1.8% and 4.9%, respectively.

    Rentokil Initial fell 3.3%, among the top FTSE 100 losers, after it said long-serving CEO was set to retire.

    The real estate sector slipped 1% after an industry survey showed that activity in Britain's construction sector contracted for a fourth month in a row in April.

    Losses came despite some progress on the global trade front, after Washington said U.S. and Chinese officials would meet in Switzerland this weekend for talks that could be the first step towards resolving a trade war disrupting the global economy.

    "The fact that there's a meeting taking place at all is an advance on where we were some weeks ago, but it's probably too much to expect a resolution on the basis of one meeting as there are so many interrelated and complicated issues to address," AJ Bell investment director Russ Mould said.

        Meanwhile, the U.S. and Britain have made good progress in negotiating a trade deal that would likely include lower tariff quotas on steel and autos, a UK official said on Tuesday. 

    Investors are now eyeing the Fed's interest rate decision later in the day, with markets expecting no change to policy.

    Among individual stocks, J D Wetherspoon's shares gained 6.1% after the British pub group's third-quarter sales rose.

    (Reporting by Ragini Mathur, Twesha Dikshit and Sanchayaita Roy in Bengaluru; Editing by Tasim Zahid and Mark Potter)

    Related Posts
    Shell mergers chief Greg Gut quits after CEO blocks bid for BP, FT reports
    Shell mergers chief Greg Gut quits after CEO blocks bid for BP, FT reports
    Exclusive-Britain examines revamp of capital rules for likes of Citadel and XTX
    Exclusive-Britain examines revamp of capital rules for likes of Citadel and XTX
    Oil slips on Russia-Ukraine peace deal talks, weak China data
    Oil slips on Russia-Ukraine peace deal talks, weak China data
    Stocks slide as investors on edge ahead of data, central bank meetings
    Stocks slide as investors on edge ahead of data, central bank meetings
    Human‑wave attacks and drones: How Myanmar's junta is fighting back
    Human‑wave attacks and drones: How Myanmar's junta is fighting back
    When Banking Delays Cross the Line: Legal Rights Around Held Checks
    When Banking Delays Cross the Line: Legal Rights Around Held Checks
    EU to relent on combustion engines ban after auto industry pressure
    EU to relent on combustion engines ban after auto industry pressure
    Dollar on defensive as traders eye delayed US jobs data
    Dollar on defensive as traders eye delayed US jobs data
    US suspends technology deal with Britain, FT reports
    US suspends technology deal with Britain, FT reports
    QuantumDiamonds announces 152 million euros investment plan for new Munich site
    QuantumDiamonds announces 152 million euros investment plan for new Munich site
    British regulator kicks off consultation on new crypto rules
    British regulator kicks off consultation on new crypto rules
    Trump sues the BBC for defamation over editing of January 6 speech, seeks up to $10 billion in damages
    Trump sues the BBC for defamation over editing of January 6 speech, seeks up to $10 billion in damages

    Why waste money on news and opinions when you can access them for free?

    Take advantage of our newsletter subscription and stay informed on the go!

    Subscribe

    More from Finance

    Explore more articles in the Finance category

    Europe to launch international commission for Ukraine war damages

    Europe to launch international commission for Ukraine war damages

    South Korea's ADEL signs up to $1.04 billion Alzheimer's drug development deal with Sanofi

    South Korea's ADEL signs up to $1.04 billion Alzheimer's drug development deal with Sanofi

    Uniper to launch sale of 20% stake in Opal gas pipeline

    Uniper to launch sale of 20% stake in Opal gas pipeline

    Trading Day: Payrolls, Fed jitters mount

    Trading Day: Payrolls, Fed jitters mount

    'Battlefield' maker EA forecasts softer 2026 bookings amid slow spending, crowded holiday slate

    'Battlefield' maker EA forecasts softer 2026 bookings amid slow spending, crowded holiday slate

    Britain clinches upgraded South Korea trade deal

    Britain clinches upgraded South Korea trade deal

    Trump says lawsuit against BBC likely to be filed soon

    Trump says lawsuit against BBC likely to be filed soon

    Tesla shares jump as Musk confirms driverless robotaxi testing

    Tesla shares jump as Musk confirms driverless robotaxi testing

    Italy's competition authority drops probe into Eni's Plenitude unit

    Italy's competition authority drops probe into Eni's Plenitude unit

    Bridgewater warns Big Tech's reliance on external capital to fund AI boom is 'dangerous'

    Bridgewater warns Big Tech's reliance on external capital to fund AI boom is 'dangerous'

    Italian firms using AI double in a year but still small minority

    Italian firms using AI double in a year but still small minority

    Juventus shares soar 19% after Agnelli family rejects crypto firm Tether's bid

    Juventus shares soar 19% after Agnelli family rejects crypto firm Tether's bid

    View All Finance Posts
    Previous Finance PostFrench reinsurer SCOR shares jump after first-quarter profit beat
    Next Finance PostPortugal allows limited power imports from Spain after blackout